Showing results (41-50 of 115) with videos related to
Sort By:
Pageof 12
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|March 8, 2018
Resting state signal latency predicts laterality in pediatric medically refractory temporal lobe epilepsyManish N Shah, Anish Mitra, Manu S Goyal, et al.Proceedings of the National Academy of Sciences of the United States of America|November 30, 2017
On the role of the corpus callosum in interhemispheric functional connectivity in humansJarod L Roland, Abraham Z Snyder, Carl D Hacker, et al.Frontiers in Immunology|November 26, 2025
Reshaping CAR-T cells through overexpression of T cell factor 1Hao Yao, Yuntian Ding, Qian Chen, et al.Neuroimage|April 11, 2020
Electrically coupled inhibitory interneurons constrain long-range connectivity of cortical networksAndrew W Kraft, Anish Mitra, Zachary P Rosenthal, et al.Neuron|April 3, 2018
Spontaneous Infra-slow Brain Activity Has Unique Spatiotemporal Dynamics and Laminar StructureAnish Mitra, Andrew Kraft, Patrick Wright, et al.Critical Care Explorations|October 16, 2020
Quantification of Neurological Blood-Based Biomarkers in Critically Ill Patients With Coronavirus Disease 2019Jennifer Cooper, Sophie Stukas, Ryan L Hoiland, et al.Cancers|April 30, 2021
Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin LymphomaFelix Korell, Maria-Luisa Schubert, Tim Sauer, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2017
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1Haruko Tashiro, Tim Sauer, Thomas Shum, et al.Cells|May 21, 2020
Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/Refractory NHL or ALLFelix Korell, Sascha Laier, Sandra Sauer, et al.Blood|July 29, 2021
CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicityTim Sauer, Kathan Parikh, Sandhya Sharma, et al.Pageof 12